← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2016Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT02973503Overall official - principal investigatorPhase 3Nov 1, 2016
Details
- Last known activity
- Oct 31, 2024